RYBELSUS 3MG TABLET 10'S

Common side effects may include nausea, vomiting, diarrhea, decreased appetite, headache, and injection site reactions.

There is a potential risk of pancreatitis with RYBELSUS 3MG TABLET 10'S. Seek medical attention if you experience severe abdominal pain.

RYBELSUS 3MG TABLET 10'S is contraindicated in individuals with a history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2). Those with a hypersensitivity to this medication should also avoid its use.

Yes, RYBELSUS 3MG TABLET 10'S has been associated with thyroid C-cell tumors in animal studies. Individuals with a history of thyroid conditions or MTC should discuss the potential risks with their healthcare provider.

RYBELSUS 3MG TABLET 10'S, especially when used with other antidiabetic medications, can increase the risk of hypoglycemia (low blood sugar). Monitoring your blood sugar levels closely and following your healthcare provider's guidance can help manage this risk.

RYBELSUS 3MG TABLET 10'S should be used cautiously in individuals with kidney impairment. Dose adjustments may be necessary based on your kidney function.

RYBELSUS 3MG TABLET 10'S has been associated with gallbladder-related events. Seek medical attention if you experience symptoms like sudden abdominal pain, particularly in the upper right side.

Discuss all medications, supplements, and herbal products you are taking with your healthcare provider, as RYBELSUS 3MG TABLET 10'S can interact with some other drugs, potentially affecting their effectiveness or increasing the risk of side effects, especially hypoglycemia when used with other antidiabetic drugs.

Discuss your medical history, monitor blood sugar closely (especially with other antidiabetics), follow dosage and administration instructions, report unusual symptoms (like abdominal pain), and consult a doctor if pregnant or breastfeeding.

The active ingredient in RYBELSUS 3MG TABLET 10'S is SEMAGLUTIDE.

RYBELSUS 3MG TABLET 10'S is prescribed for the treatment of Diabetes.

RYBELSUS 3MG TABLET 10'S (Semaglutide) is a GLP-1 receptor agonist that works by helping the body produce more insulin when blood sugar is high, reducing the amount of sugar produced by the liver, and slowing down digestion. This helps lower blood sugar levels in people with Type 2 Diabetes.